Viking Therapeutics, Inc. SEC filings VKTX
Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Sep 25, 2026 | — |
| 424B5 | Prospectus supplement | Sep 25, 2026 | — |
| FWP | Free writing prospectus | Sep 24, 2026 | — |
| 424B5 | Prospectus supplement | Sep 23, 2026 | — |
| 424B5 | Prospectus supplement | Sep 23, 2026 | — |
| S-3ASR | Automatic shelf registration | Jul 30, 2026 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 23, 2024 | — |
| S-8 POS | Filing | May 22, 2024 | — |
| S-8 | Employee stock plan registration | May 22, 2024 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 27, 2024 | — |
| S-8 | Employee stock plan registration | Feb 7, 2024 | — |
| S-3ASR | Automatic shelf registration | Jul 26, 2023 | — |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| 424B5 | Prospectus supplement | Mar 29, 2023 | — |
| S-8 | Employee stock plan registration | Feb 10, 2023 | — |
| S-8 | Employee stock plan registration | Feb 9, 2022 | — |
| 424B5 | Prospectus supplement | Aug 11, 2021 | — |
| S-3 | Shelf registration | Jul 28, 2021 | — |
| S-8 | Employee stock plan registration | Feb 17, 2021 | — |
| S-8 | Employee stock plan registration | Feb 26, 2020 | — |
| 424B5 | Prospectus supplement | Aug 2, 2019 | — |
| S-8 | Employee stock plan registration | Mar 13, 2019 | — |
| 424B5 | Prospectus supplement | Sep 21, 2018 | — |
| 424B5 | Prospectus supplement | Sep 19, 2018 | — |
| S-3 | Shelf registration | Jul 11, 2018 | — |
| 424B5 | Prospectus supplement | Jun 7, 2018 | — |
| S-3MEF | S-3 mef | Jun 7, 2018 | — |
| 424B5 | Prospectus supplement | Jun 6, 2018 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| 424B5 | Prospectus supplement | Feb 5, 2018 | — |
| 424B5 | Prospectus supplement | Feb 1, 2018 | — |
| 424B3 | Prospectus | Jan 16, 2018 | — |
| S-1/A | Amended registration statement | Jan 9, 2018 | — |
| S-1 | Registration statement | Dec 20, 2017 | — |
| 424B5 | Prospectus supplement | Dec 7, 2017 | — |
| 424B5 | Prospectus supplement | Dec 5, 2017 | — |
| 424B3 | Prospectus | Oct 26, 2017 | — |
| S-1 | Registration statement | Oct 17, 2017 | — |
| 424B5 | Prospectus supplement | Sep 29, 2017 | — |
| 424B5 | Prospectus supplement | Jun 15, 2017 | — |
| 424B3 | Prospectus | Mar 27, 2017 | — |
| S-8 | Employee stock plan registration | Mar 21, 2017 | — |
| S-3 | Shelf registration | Feb 14, 2017 | — |
| 424B3 | Prospectus | Sep 26, 2016 | — |
| S-1 | Registration statement | Sep 2, 2016 | — |
| S-3/A | Filing | Jul 26, 2016 | — |
| S-3 | Shelf registration | Jun 20, 2016 | — |
| S-8 | Employee stock plan registration | May 10, 2016 | — |
| 424B4 | Prospectus | Apr 8, 2016 | — |
| S-1MEF | Filing | Apr 7, 2016 | — |
| S-1/A | Amended registration statement | Apr 4, 2016 | — |
| S-1/A | Amended registration statement | Apr 1, 2016 | — |
| S-1/A | Amended registration statement | Mar 25, 2016 | — |
| S-1/A | Amended registration statement | Mar 8, 2016 | — |
| S-1 | Registration statement | Nov 24, 2015 | — |
| S-8 | Employee stock plan registration | May 1, 2015 | — |
| 424B4 | Prospectus | Apr 29, 2015 | — |
| S-1MEF | S-1 mef | Apr 28, 2015 | — |
| FWP | Free writing prospectus | Apr 22, 2015 | — |
| S-1/A | Amended registration statement | Apr 22, 2015 | — |
| S-1/A | Amended registration statement | Apr 10, 2015 | — |
| S-1/A | Amended registration statement | Mar 2, 2015 | — |
| S-1/A | Amended registration statement | Sep 16, 2014 | — |
| S-1/A | Amended registration statement | Sep 8, 2014 | — |
| S-1/A | Amended registration statement | Sep 2, 2014 | — |
| S-1 | Registration statement | Jul 1, 2014 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1607678
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.